Eling Pharmaceutical (002603.SZ) Sun Company received the European CEP certificate for anastrozole APIs

Zhitong Finance App News, Eling Pharmaceutical (002603.SZ) announced that recently, Wanyang Hengshui Pharmaceutical Co., Ltd. (“Hengshui Wanyang”), a wholly-owned subsidiary of the company, received the European Pharmacopeia Certificate of Suitability (“CEP Certificate”) for anastrozole APIs issued by the European Medicines Quality Administration (EDQM).

According to reports, Anastrozole (Anastrozole) is a drug widely used to treat estrogen-related tumors. This time, Hengshui Wanyang obtained the CEP certificate for anastrozole, which shows that the European regulatory market recognizes and affirms the quality of this API. It indicates that the product has the qualifications to enter the European Union and other markets that recognize CEP certificates in the form of APIs, which has had a positive impact on the company's further expansion of the international market.